INVO Bioscience, Inc. (INVO)
Stock Price:
$3.75 USD
-0.19 (-4.82%)
Updated Oct 28, 2020 3:31 PM EDT - Market closed
Key Info
| Market Cap |
29.72M |
| Revenue (ttm) |
1.14M |
| Net Income (ttm) |
-4.23M |
| Shares Out |
7.93M |
| EPS (ttm) |
-0.53 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Oct 28, 2020 |
| Last Price |
$3.75 |
| Previous Close |
$3.94 |
| Change ($) |
-0.19 |
| Change (%) |
-4.82% |
| Day's Open |
3.90 |
| Day's Range |
3.75 - 3.90 |
| Day's Volume |
4,780 |
| 52-Week Range |
0.12 - 5.5 |
More Stats
| Market Cap |
29.72M |
| Enterprise Value |
n/a |
| Earnings Date (est) |
n/a |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
7.93M |
| Float |
5.00M |
| EPS (basic) |
n/a |
| EPS (diluted) |
-0.53 |
| FCF / Share |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
n/a |
| Payout Ratio |
n/a |
| Shares Short |
n/a |
| Short Ratio |
n/a |
| Short % of Float |
n/a |
| Beta |
-0.74 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| P/FCF Ratio |
n/a |
| PS Ratio |
26.15 |
| PB Ratio |
n/a |
| Revenue |
1.14M |
| Operating Income |
n/a |
| Net Income |
-4.23M |
| Free Cash Flow |
n/a |
| Net Cash |
n/a |
| Net Cash / Share |
n/a |
| Gross Margin |
117.92% |
| Operating Margin |
n/a |
| Profit Margin |
n/a |
| FCF Margin |
n/a |
| ROA |
-81.97% |
| ROE |
n/a |
| ROIC |
n/a |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Forecasts
Analyst Ratings (0)
| Buy |
0 |
| Overweight |
0 |
| Hold |
0 |
| Underweight |
0 |
| Sell |
0 |
*No analysts have provided price targets for this stock.
Financial Overview
No financial data available for this stock yet.
Company Details
| Full Name |
INVO Bioscience, Inc. |
| Country |
United States |
| Employees |
5 |
| CEO |
Steven M. Shum |
Stock Information
| Ticker Symbol |
INVO |
| Stock Exchange |
US OTC |
| Sector |
Healthcare |
| Industry |
Medical Devices |
| Unique Identifier |
OTCMKTS: INVO |
Description
INVO Bioscience, a medical device company, provides assisted reproductive technology solutions worldwide. The company offers INVOcell, a patented intravaginal culture system used for the natural in vivo incubation of eggs and sperm during fertilization and early embryo development; and INVOcell Retention device, a single-use modified diaphragm that includes holes to allow for natural drainage of vaginal fluids to aid in retention of the INVOcell device in the vaginal cavity during the incubation period. It also provides fixed laboratory equipment comprising microscopes with video systems, bench centrifuges, incubators without CO2, bench warmers, and laminar flow hoods. The company sells its products to physicians and IVF centers. INVO Bioscience, Inc. was founded in 2007 and is based in Sarasota, Massachusetts.